Zymeworks (ZYME) Depreciation and Depletion (2022 - 2026)
Zymeworks recorded quarterly Depreciation and Depletion of $963000.0 in Q1 2026, up 7.24% quarter-over-quarter from $898000.0 in Q4 2025, and down 1.83% year-over-year from $981000.0 in Q1 2025.
Zymeworks' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $963000.0 for Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 1.83% year-over-year to $963000.0; the TTM figure through Mar 2026 stood at $3.7 million (down 11.12% YoY), while the FY2025 annual figure was $3.7 million, down 12.39% from the prior year.
- Depreciation and Depletion came in at $963000.0 for Q1 2026 at Zymeworks, up from $898000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $2.4 million in Q3 2023 to a low of $885000.0 in Q2 2025.
- A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion jumped 73.36% in 2023 and plunged 56.89% in 2024, its largest moves.
- Zymeworks' Depreciation and Depletion stood at $1.2 million in 2022, then soared by 33.33% to $1.5 million in 2023, then plunged by 35.09% to $997000.0 in 2024, then declined by 9.93% to $898000.0 in 2025, then rose by 7.24% to $963000.0 in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $963000.0, $898000.0, and $905000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 963,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 963,000.00 |
| Mar 31, 2026 | 963,000.00 |
| Dec 31, 2025 | 898,000.00 |
| Dec 31, 2025 | 898,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 885,000.00 |
| Mar 31, 2025 | 981,000.00 |
| Mar 31, 2025 | 981,000.00 |
| Dec 31, 2024 | 997,000.00 |
| Dec 31, 2024 | 997,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Mar 31, 2022 | 2.31 Mn |